Newsletter | October 12, 2023

10.12.23 -- Find A Data-Driven Approach To Container Closure Integrity

Selecting Container Closure Components: A Data-Driven Approach To CCI

In this article, see how West is supporting pharmaceutical partners in the critical container closure area through an efficient, data-driven process that employs innovative methods to accelerate the selection of a closure containment system that meets the requirements of the modern regulatory landscape.

 

Key Considerations For Selecting Fill/Finish Manufacturing Technologies

Manufacturing planning is a critical step in the path to commercialization and helps companies accelerate their path to market. Obtaining information and proactively mapping out your fill/finish strategy early can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.

 

De-Risking Visible Particles Through Component Selection

The draft guidance “Inspection of Injectable Products for Visible Particulates” is intended to clarify the various areas where controls must be in place for a successful particle control strategy that meets regulatory expectations. This article is a summary of the draft guidance and how it applies to components.

 

The 10 Most Frequently Asked Questions On Glass – Part I

Dr. Bettine Boltres, whose role involves supporting pharmaceutical companies to address glass-related topics from a scientific perspective and to gain a deeper understanding of the material that holds their valuable drug products, answers the most commonly asked questions she encounters around glass vials.

 

The Packaging And Containment Strategy To Get Products To Market Faster

Emerging biopharmaceuticals are powering impressive leaps in medical innovation by developing some of today’s most promising new molecules in the form of injectable biologics. A proactive approach is needed to overcome regulatory hurdles, manage lean resources, and accelerate development.

 

 


 

Developing a drug and getting it approved is no small feat, particularly amid key trends that are reshaping the market — and if you’re an emerging company, you have unique challenges compared to larger companies. Selecting the right drug packaging positively impacts the success and timeline of bringing your drug to market.

 

Read more here about emerging biotech challenges and West solutions to mitigate risk and reduce obstacles that slow development.

 

To learn more about containment solutions for emerging companies, please read about the West Ready Pack™ containment solution here.

 

We invite you to Contact Us so that we can connect you with a West account manager in your region.